Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series.
Gori N, Ippoliti E, Ferrucci SM, Balato A, Ortoncelli M, Maurelli M, Galluzzo M, Munera Campos M, Seremet T, Di Nardo L, Antonelli F, Coscarella G, Conrad C, Carrascosa JM, Bianchi L, Argenziano G, Ribero S, Girolomoni G, Marzano AV, Chiricozzi A, Peris K; MEDaCoTRA Study Group. Gori N, et al. Among authors: ortoncelli m. J Eur Acad Dermatol Venereol. 2024 Feb 29. doi: 10.1111/jdv.19929. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38421043 No abstract available.
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study.
Quaglino P, Marenco F, Osella-Abate S, Cappello N, Ortoncelli M, Salomone B, Fierro MT, Savoia P, Bernengo MG. Quaglino P, et al. Among authors: ortoncelli m. Ann Oncol. 2010 Feb;21(2):409-414. doi: 10.1093/annonc/mdp325. Epub 2009 Jul 21. Ann Oncol. 2010. PMID: 19622589 Free article.
Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study.
Borroni RG, Malagoli P, Gargiulo L, Valenti M, Pavia G, Facheris P, Morenghi E, Di Corteranzo IG, Narcisi A, Ortoncelli M, Dapavo P, Costanzo A. Borroni RG, et al. Among authors: ortoncelli m. Acta Derm Venereol. 2021 Nov 30;101(11):adv00605. doi: 10.2340/actadv.v101.283. Acta Derm Venereol. 2021. PMID: 34596230 Free PMC article.
Efficacy of dupilumab in prurigo nodularis in elderly patient.
Giura MT, Viola R, Fierro MT, Ribero S, Ortoncelli M. Giura MT, et al. Among authors: ortoncelli m. Dermatol Ther. 2020 Jan;33(1):e13201. doi: 10.1111/dth.13201. Epub 2019 Dec 28. Dermatol Ther. 2020. PMID: 31856368
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in adult cohort: a real-life Italian tertiary centre experience.
Ribero S, Giura MT, Viola R, Ramondetta A, Siliquini N, Cardone P, Tonella L, Quaglino P, Dapavo P, Panzone M, Ortoncelli M, Fierro MT. Ribero S, et al. Among authors: ortoncelli m. J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e380-e383. doi: 10.1111/jdv.16219. Epub 2020 May 22. J Eur Acad Dermatol Venereol. 2020. PMID: 31960496 No abstract available.
97 results